In the evaluation of thyroid nodules the three major clinical concerns are malignancy, hyperfunction, and cosmetic effect. It is now well accepted that the isolated "cold" nodule is the clinical setting in which thyroid cancer most often occurs (1-2). The clinical problem most often inferred from the presence of a "hot" nodule is hyperfunction. However, the clinical course, and natural history of this lesion are not as clearly defined as for many other thyroid conditions. We have evaluated our past experience with this disease in an attempt to define the implications of the discovery, in a patient, of a "hot" nodule. Data are presented in a manner distinct from the usual consideration of whether a "hot" nodule is suppressible or not.
stringent than are used clinically. However, by using these levels we would tend to include more patients in the "hyperfunction" group, and if anything, overemphasize any possible progression of patients from the euthyroid to hyperthyroid categories (25% of all cases).
Group IV. Patients with the appearance of a hot nodule on scan, whose actual diagnosis fell into other categories (e.g., thyroiditis, hypothryoidism, etc.). These occurred in numbers too small to analyze statistically ( 11% of all cases).
Each of the first three groups was analyzed in terms of sex, mean age, age distribution, length and surface area of the nodule, and radioiodide uptake per unit of scan surface area. In addition, a subjective judgment was made as to whether the nodule was suppressing the remaining thyroid gland to the extent of 90% or more (by comparing the density of the nodule with nearby tissue). Uptake studies were performed after use of 5-10 MUCi of 131I-Na, while most scans were performed after use of about 3 mCi of sodium pertechnetate.
RESULTS
Groups I, II, and III are compared in Table 1 . The average length of follow-up was 14.1 months for group II (range 1-68) and 28.7 months for group III (range 1-72).
Sex. The female to male ratio in each of the three groups was greater than eight to one.
Age. If there had been a significant progression of patients from group II to group III during the course of the disease (that is, having an elevated radioiodide uptake), patients in group III would be expected to be older than those in group II. The mean ages of these groups was not statistically different. This same information (Groups II and III), plotted in terms of a probability distribution ( Fig.  1) showed lines which were not significantly different, and they (as well as the curve for Group I) were approximately normally distributed.
Length. The length of the nodule, as it appeared on a rectilinear scan, without contrast enhancement, was measured. Groups II and III were statistically different (P < 0.005) and the data for group III was approximately normally distributed (Fig. 2) . The data from groups I and II were also normally distributed.
Surface area. Mean surface areas of the hot nodules in the three groups (measured by planimeter) were compared. The mean surface area of hot nodules from group II was significantly less than group III.
Uptake. In those cases in which there was suppression of the remaining thyroid (as judged from the scan), an estimate of the uptake/cm2 of scan surface area (5) reported on a series of 53 patients in whom the diagnosis of "solitary hyperfunctioning nodule" was made on initial study. Only one patient developed hyperthyroidism from increased function within the nodule. Silverstein et al. (6) described the long-term follow-up in nine cases of hot nodules of the thyroid. They noted four distinct courses: persistent autonomy, persistant autonomy with reduced function, partial resumption of TSH dependence, and (in one case) degeneration of the nodule.
Our results are consistant with the latter three series, in that we found "hot nodules," as noted on scan, to be a heterogeneous group in terms of etiology as well as physiologic response. The single largest number of cases of "hot nodule" turned out to be due to prior surgery. Presumably these do not represent loss of the normal pituitary-thyroid axis function.
Of the patients in Groups II and III, we found that 52% had elevated radioiodide uptakes, by our admittedly stringent criteria. We do not have sufficient clinical data to support the diagnosis of hyperthyroidism in all these patients however. We feel that the functional status can not be inferred from the thyroid scan alone.
While 57% of the patients in the elevated radioiodide-uptake group showed scan suppression of the surrounding and contralateral thyroid tissue, 63% of the patients with a hot nodule and normal radioiodide uptake showed the same finding. It would seem logical to assume that suppression of the surrounding thyroid tissue indicates autonomous function in relation to TSH. The above results do not support this contention. Further, the results of the limited number of T3-suppression tests performed are counter to this conclusion. As expected, of nine patients in the elevated radioiodide uptake group tested, none showed suppression of the nodule. In the normal radioiodide uptake group, however (again with the nodule the only functional tissue seen on scan), four or five patients tested showed suppression after T3 treatment. The division of patients into suppressible or nonsuppressible may be less significant than previously thought. Whether any of the patients had T3 toxicosis is unknown.
We found that the progression of patients from the normal radioiodide uptake group to that with elevated uptake was strikingly small. We are aware of only one patient in our series who showed progression from the euthyroid state, with normal radioiodide uptake, to the clinically hyperthyroid state, with an elevated, nonsuppressible uptake (Fig. 3) .
Miller and Hamburger in 1965 (7) noted that no primary carcinoma of the thyroid had been reported presenting as an autonomous nodule, although "incidental" thyroid carcinoma had been found at operation coincidentaly with autonomous nodules. In 1971 Meier and Hamburger (8) reported a case of carcinoma and an autonomous nodule in a patient who had previously had radiotherapy. They reported three other patients with radiation who developed autonomous nodules and they suggested an etiologic relationship. We are unaware of any patients in our series with a similar history. Further, there were no thyroid cancers in 10 patients in our series who underwent surgery.
From the above results we draw the conclusion that this is a relatively benign disease in both the physiologic as well as the histologic sense. The incidence of cancer and/or progression to the clinically hyperthyroid state is very low. Thus, we feel there is sufficient justification for the conservative management of this problem ("watchful waiting" unless there are symptoms), reserving surgery for those patients with clear evidence of progression of the disease. 
SUMIMARY
As judged by an area of increased uptake on a thyroid scan, 133 cases were selected. Thirty-seven percent of these had prior surgery on the neck and another 11 % were judged to be due to thyroiditis or other miscellaneous causes. The remaining cases were divided into two classes, depending on whether the thyroidal radioiodide uptake value was above or below rather stringent criteria. Evidence was presented that there was little movement from the group with "normal" radioiodide uptake values into the hyperthyroid range. On the basis of this finding, and the benign nature of the lesions found in 10 patients who did undergo thyroid surgery, it was concluded that the "hot" nodules are relatively benign and that conservative management is likely indicated.
